Because of the side effects of levodopa use, people diagnosed with Parkinson’s often choose to delay treatment with levodopa and start with other approved therapies. Typically, the first step is to start with medications that mimic levodopa, like Pramipexole, or medications that help increase natural dopamine levels, like Rasagiline. This clinical trial (phase 3) will research whether combining those two therapies at lower doses will result in good therapeutic effect, with fewer side effects. A previous clinical trial (Phase IIb) of the combination therapy showed positive results.
If you would like to speak to someone regarding this trial first check to see if you are eligible below. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional eligiblity questions, and you will be able to ask any additional questions you may have about this clinical trial.
Clinical trials (also called clinical research) are research studies to determine whether investigational drugs or treatments are safe and effective for humans. All investigational medications and devices must undergo clinical trials before they are made available to patients.
Before you can participate in any clinical trial, you will be asked to review and sign an informal consent form (ICF), which will explain the potential benefits, risks, and side effects that you may experience while taking part in the clinical trial. Signin it indicates you are agreeing to take part in this research study.
You can decide to leave a clinical trial at any time, and you do not have to give a reason. There is no charge or penalty if you decide not to take part in a clinical trial.
You will have access to investigational medications that, if approved, will be available to the general public. You will also receive study-related medical care and attention from clinical trial staff at research facilities. Clinical trials offer an opportunity to help researchers find better treatments for others in the future.
The investigational treatment may or may not help to make your condition better. While you may have a positive experience, you may also experience unpleasant or serious side effects. It's important to discuss the benefits and risks with either your doctor or the clinical trial site contact before making any decisions.
Your information will be kept confidential within the limits of the law of your country. If the results of this clinical trial are published or presented in a meeting, you will not be named and nobody will be able to tell that you were in the trial from the publication or presentation.
If you would like to speak to someone regarding this trial first check above to see if you are eligible. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional eligiblity questions, and you will be able to ask any additional questions you may have about this clinical trial.